Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
- 21 September 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 28 (50), 4409-4420
- https://doi.org/10.1038/onc.2009.295
Abstract
A major impediment to the effective treatment of cancer is the molecular heterogeneity of the disease, which is also reflected in an equally diverse pattern of clinical responses to therapy. Currently, only few drugs are available that can be used safely and effectively to treat cancer. To improve this situation, the development of novel and highly specific targets for therapy is of utmost importance. Possibly even more importantly, we need better tools to predict which patients will respond to specific therapies. Such drug response biomarkers will be instrumental to individualize the therapy of patients having seemingly similar cancers. In this study, we discuss how RNA interference-based genetic screens can be used to address these two pressing needs in the care for cancer patients.This publication has 88 references indexed in Scilit:
- Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screenProceedings of the National Academy of Sciences of the United States of America, 2008
- A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast CancerCancer Cell, 2007
- Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 DisruptionsMolecular and Cellular Biology, 2006
- Identification of pathways regulating cell size and cell-cycle progression by RNAiNature, 2006
- Genome-wide RNAi analysis of JAK/STAT signaling components in DrosophilaGenes & Development, 2005
- A large-scale RNAi screen in human cells identifies new components of the p53 pathwayNature, 2004
- New tools for functional mammalian cancer geneticsNature Reviews Cancer, 2003
- Identification of Modulators of TRAIL-Induced Apoptosis via RNAi-Based Phenotypic ScreeningMolecular Cell, 2003
- Lentiviral-Mediated RNA InterferenceHuman Gene Therapy, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002